Klepser ME - Search Results

1

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.

Roling EE, Klepser ME, Wasson A, Lewis RE, Ernst EJ, Pfaller MA. Roling EE, et al. Among authors: klepser me. Diagn Microbiol Infect Dis. 2002 May;43(1):13-7. doi: 10.1016/s0732-8893(02)00361-9. Diagn Microbiol Infect Dis. 2002. PMID: 12052624

2

Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.

Ernst EJ, Yodoi K, Roling EE, Klepser ME. Ernst EJ, et al. Among authors: klepser me. Antimicrob Agents Chemother. 2002 Feb;46(2):578-81. doi: 10.1128/AAC.46.2.578-581.2002. Antimicrob Agents Chemother. 2002. PMID: 11796383 Free PMC article.

3

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies.

Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME. Ernst EJ, et al. Among authors: klepser me. Antimicrob Agents Chemother. 2002 Dec;46(12):3846-53. doi: 10.1128/AAC.46.12.3846-3853.2002. Antimicrob Agents Chemother. 2002. PMID: 12435687 Free PMC article.

4

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA. Klepser ME, et al. Antimicrob Agents Chemother. 1997 Jun;41(6):1392-5. doi: 10.1128/AAC.41.6.1392. Antimicrob Agents Chemother. 1997. PMID: 9174207 Free PMC article.

5

Update on antifungal resistance.

Klepser ME, Ernst EJ, Pfaller MA. Klepser ME, et al. Trends Microbiol. 1997 Sep;5(9):372-5. doi: 10.1016/S0966-842X(97)01108-6. Trends Microbiol. 1997. PMID: 9294895 Review.

6

Growth medium effect on the antifungal activity of LY 303366.

Klepser ME, Ernst EJ, Ernst ME, Pfaller MA. Klepser ME, et al. Diagn Microbiol Infect Dis. 1997 Dec;29(4):227-31. doi: 10.1016/s0732-8893(97)00144-2. Diagn Microbiol Infect Dis. 1997. PMID: 9458979

7

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.

Klepser ME, Wolfe EJ, Pfaller MA. Klepser ME, et al. J Antimicrob Chemother. 1998 Mar;41(3):397-401. doi: 10.1093/jac/41.3.397. J Antimicrob Chemother. 1998. PMID: 9578168

8

Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.

Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Klepser ME, et al. Antimicrob Agents Chemother. 1998 May;42(5):1207-12. doi: 10.1128/AAC.42.5.1207. Antimicrob Agents Chemother. 1998. PMID: 9593151 Free PMC article.

9

Update on clinical antifungal susceptibility testing for Candida species.

Lewis RE, Klepser ME, Pfaller MA. Lewis RE, et al. Among authors: klepser me. Pharmacotherapy. 1998 May-Jun;18(3):509-15. Pharmacotherapy. 1998. PMID: 9620102 Review.

10

Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.

Lewis RE, Lund BC, Klepser ME, Ernst EJ, Pfaller MA. Lewis RE, et al. Among authors: klepser me. Antimicrob Agents Chemother. 1998 Jun;42(6):1382-6. doi: 10.1128/AAC.42.6.1382. Antimicrob Agents Chemother. 1998. PMID: 9624480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters